Last $66.44 USD
Change Today -1.26 / -1.86%
Volume 1.2M
ENDP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Toronto
As of 12:51 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

endo international plc (ENDP) Snapshot

Open
$67.41
Previous Close
$67.70
Day High
$67.41
Day Low
$66.38
52 Week High
03/4/14 - $82.16
52 Week Low
10/31/13 - $43.12
Market Cap
10.2B
Average Volume 10 Days
2.6M
EPS TTM
$0.14
Shares Outstanding
153.5M
EX-Date
--
P/E TM
491.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for ENDO INTERNATIONAL PLC (ENDP)

endo international plc (ENDP) Related Businessweek News

View More BusinessWeek News

endo international plc (ENDP) Details

Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women’s health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men’s and women’s health, and prostate health. The company’s products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

3,371 Employees
Last Reported Date: 03/3/14
Founded in 1920

endo international plc (ENDP) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $4.3M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $157.0K
Chief Legal Officer, Executive Vice President...
Total Annual Compensation: $562.0K
Chief Operating Officer of Pharmaceuticals
Total Annual Compensation: $270.8K
Compensation as of Fiscal Year 2013.

endo international plc (ENDP) Key Developments

Auxilium Pharmaceuticals Inc., Endo International plc - M&A Call

To discuss the proposal to acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc

Endo Seeks Acquisitions

Endo International plc (NasdaqGS:ENDP) will consider acquisitions. Endo has proposed to acquire Auxilium Pharmaceuticals Inc. (NasdaqGS:AUXL) and the combined company will be well positioned to drive organic growth and to capitalize on additional future merger and acquisition opportunities.

Endo International plc Provides Tax Guidance for the Year 2014

Endo International plc provided tax guidance for the year 2014. The company expects to exit 2014 with a low-20s tax rate.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENDP:US $66.44 USD -1.26

ENDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $146.90 USD -0.33
Dr Reddy's Laboratories Ltd 3,212 INR -11.25
Edwards Lifesciences Corp $104.13 USD +0.11
Mallinckrodt PLC $88.18 USD -0.64
Varian Medical Systems Inc $81.55 USD -1.08
View Industry Companies
 

Industry Analysis

ENDP

Industry Average

Valuation ENDP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.0x
Price/Book 3.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDO INTERNATIONAL PLC, please visit www.endo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.